Grace Therapeutics (GRCE) Stock: Buy, Sell, or Hold?
GRCE - Grace Therapeutics, Inc. Common Stock
$2.07
0.03 (1.47%)
▲
5d:
-2.36%
30d:
-3.27%
90d:
-18.18%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When GRCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GRCE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GRCE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: GRCE is currently trading at $2.07, which is considered oversold relative to its 30-day fair value range of $2.09 to $2.19.
Technical Outlook: Technically, GRCE is in a downtrend. Immediate support is located at $1.98, while resistance sits at $2.18.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.87 (+183.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRCE is in a downtrend. Immediate support is located at $1.98, while resistance sits at $2.18.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.87 (+183.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.09 -
$2.19
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 183.6% below Wall St target ($5.87)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.09 -
$2.19
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.98
Resistance Level
$2.18
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.18
Wall Street Target
$5.87
(+183.6%)
Share & Embed Analysis
Last updated: October 04, 2026 1:18 AM ET
Data refreshes hourly during market hours. Next update: 2:18 AM
Data refreshes hourly during market hours. Next update: 2:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |